January 2026 kicked off with strong momentum in healthtech fundraising, with startups across AI‑powered care, digital health, femtech, clinical workflow automation, and behavioural health securing capital.
From pre‑seed to late‑stage rounds, funding activity underscores continuing investor confidence in solutions that address clinical bottlenecks, patient experience, and care accessibility.
Here’s a snapshot of the major healthtech funding announcements from the month:
Oviva
Funds raised: €200 million (~US $220 Mn)
Round: Series D
Investors: Led by Kinnevik; participation from Planet First Partners, A.P. Moller Holding, Lunate, EGS Beteiligungen AG, Norrsken VC, and continued support from Sofina
About: Europe-based digital health provider delivering reimbursed chronic care and weight management via an AI-enabled app and multidisciplinary clinical teams, treating over 1 million patients across national systems.
How it plans to use the funds: Expand platform into additional chronic indications (e.g., hypertension and Type 2 diabetes), advance AI-tools, and scale access across European health systems.
Nivaan Care
Funds raised: USD 7 million (~₹64.2 cr)
Round: Series A
Investors: Sorin Investments (lead), W Health Ventures, Endiya Partners, Rebright Partners
About: New Delhi-based healthtech startup operating single-speciality clinics focused on non-surgical and minimally invasive chronic pain management.
How it plans to use the funds: Expand clinic network across Indian cities (including Bengaluru), strengthen clinical and operational infrastructure, and advance minimally invasive pain management procedures.
OSSO: Next-Gen Orthopaedics
Funds raised: ₹4 crore (~US $443 K)
Round: Seed
Investors: Led by the Haldiram family office; participation from angel investors including Sahil Jindal (Jindal Group), Aakashdeep Goyal (Culture Cap), Parijat Sharma (ZS Associates) and Viraj Patel (DotShot)
About: Gurugram-based healthcare startup focused on regenerative orthopaedics and musculoskeletal care, combining minimally invasive procedures, physiotherapy and traditional treatments.
How it plans to use the funds: Expand their network of orthopaedic centres with plans for three new clinics in Gurugram and introduce advanced diagnostics like nanoscopy in India.
BrightHeart
Funds raised: €11 million (~US$12.8 M)
Round: Series A
Investors: Co-led by Odyssée Venture and GO Capital, with participation from Mussallem CHD Alliance, Lift Value, IDAHO HealthTech Club via SideAngels, and Sofinnova Partners (founding investor), plus clinician and angel backers.
About: Paris-based AI healthtech developing the B-Right platform, an AI-driven prenatal ultrasound solution that improves congenital heart defect (CHD) screening and streamlines exams.
How it plans to use the funds: Expand U.S. commercialisation; grow presence across Europe; and advance product innovation and clinical adoption of their AI prenatal ultrasound platform.
Clue
Funds raised: Undisclosed
Round: Growth/Strategic Investment
Investors: Verdane (European specialist growth equity firm)
About: Berlin-based femtech app for period and cycle tracking with 100M+ downloads, helping users monitor menstrual health and build evidence-based wellness insights.
How it plans to use the funds: Accelerate product innovation and UX; expand in new and existing global markets; invest in healthcare partnerships, clinical research, and personalized care technology while strengthening privacy and data security.
Even Healthcare
Funds raised: USD 20 million (~₹180 crore)
Round: Extended Series A
Investors: Lachy Groom and Alpha Wave Global (lead), with participation from Sharrp Ventures | Harsh Mariwala Investment Office
About: Bengaluru-based managed-care healthtech blending primary care, diagnostics, and hospital treatment under an integrated patient-centric model focused on outcomes and recovery.
How it plans to use the funds: Expand the managed-care hospital footprint in Bengaluru and scale the integrated care model.
OpenEvidence
Funds raised: US $250 million
Round: Series D
Investors: Co‑led by Thrive Capital and DST Global; also participated by Sequoia Capital, Google Ventures, Nvidia, Kleiner Perkins, Blackstone, Coatue, ICONIQ, Greycroft, Breyer Capital, BOND, Craft Ventures, Mayo Clinic, and others
About: OpenEvidence is providing a clinician‑focused AI medical search and decision support platform that synthesises evidence from peer‑reviewed clinical literature to support doctors at the point of care.
How it plans to use the funds: Expand operations, accelerate R&D on AI tech, grow adoption among healthcare systems, and scale platform capabilities to serve clinicians globally.
Omniscient Neurotechnology
Funds raised: USD 20 million
Round: Series D
Investors: National Reconstruction Fund Corporation (NRFC) leading; co‑led with OIF Ventures
About: Sydney‑based AI neurotech developing Quicktome®, an FDA‑approved AI platform that maps individual brain connections from MRI scans to help personalise neurological care and surgical planning.
How it plans to use the funds: Commercialise and scale the Quicktome platform globally, grow the data science team, and develop next‑generation clinical applications for its brain mapping tech.
Luminate
Funds raised: US $21 million
Round: Expanded Series A
Investors: Led by ARTIS Ventures and Lachy Groom; participation from Western Alliance Life Sciences, 8VC, Y Combinator, Atlantic Bridge, Faber, SciFounders, and others
About: Galway, Ireland‑based healthtech company building services and devices to enable cancer treatments, including infusions and side‑effect reduction tools, delivered in the home to improve patient experience and clinical capacity.
How it plans to use the funds: Launch home‑based cancer care access across ~40 partner oncology clinics; scale deployment of patient‑led infusion technologies, and expand clinical trials for related medical devices.
Evaro
Funds raised: USD $25 million
Round: Series A
Investors: AlbionVC (lead), Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI.
About: Norwich, UK‑based NHS‑licensed digital healthcare platform offering healthcare‑as‑a‑service, embeddable digital pharmacy infrastructure enabling asynchronous consultations, prescribing, dispensing and aftercare in partnership with brands and platforms.
How it plans to use the funds: Scale their healthcare infrastructure services across consumer brands, expand treatment areas (women’s, men’s and longevity medicine), enhance clinical and diagnostic capabilities, and broaden API integrations.
Zeya Health
Funds raised: US $5.75 Million
Round: Pre‑seed
Investors: Led by Antler with participation from strategic angel investors
About: Singapore‑based AI‑native healthcare operations platform that automates administrative clinic workflows (e.g., reminders, follow‑ups, scheduling, patient engagement) by integrating with existing EMRs and comms.
How it plans to use the funds: Support product development, scale deployments across Singapore and broader Asia‑Pacific outpatient markets, and hire engineers and clinical deployment specialists.
Oasys Health
Funds raised: US $4.6 million
Round: Combined Seed & Pre‑seed
Investors: Pathlight Ventures (lead), Twine Ventures, Better Ventures; Pre‑seed from 1984 Ventures
About: New York‑based AI‑native operating system for behavioural health that automates clinic workflows (documentation, billing, scheduling) while integrating data from wearables and health apps to support measurable, data‑driven mental healthcare.
How it plans to use the funds: Enhance the AI platform, deepen integrations with wearables and health apps, grow engineering and data science teams, and expand partnerships with clinics, behavioural health centers, MSOs, and universities.
Wrapping up
January’s funding landscape highlights the diversity and dynamism of the healthtech ecosystem, from AI‑first platforms and chronic care solutions to integrated clinical‑tech models.
Investors continue to back startups that bring measurable impact to providers and patients alike, setting the stage for further innovation and growth in the quarters ahead.
Source: HealthTech Alpha’s funding data
We’re the exclusive HealthTech Alpha partners in India! Reach out if you’re looking for deeper market intelligence or strategic perspectives.
